Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Oligomers of hepatitis A virus (HAV) capsid protein VP1 generated in a heterologous expression system

7 Apr 2022

Abstract excerpt

BACKGROUND: The quasi-enveloped picornavirus, Hepatitis A Virus (HAV), causes acute hepatitis in humans and infects approximately 1.5 million individuals a year, which does not include the asymptomatically infected population. Several severe outbreaks in developing nations in recent years have highlighted the reduction in HAV endemicity, which increases the risk of infections in the vulnerable population. The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hepatitis Viruses Studies and Epidemiology
Share to Viral gastroenteritis research and epidemiology
Share to Viral Infections and Immunology Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35392916
DOI: 10.1186/s12934-022-01780-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Oligomers of hepatitis A virus (HAV) capsid protein VP1 generated in a heterologous expression systemPMID 35392916Read ↗

Preclinical Development and Production of Virus-Like Particles As Vaccine Candidates for Hepatitis CSemantic proximity Read ↗

Expression, purification and characterization of enterovirus-71 virus-like particlesSemantic proximity Read ↗

Optimized production strategy of the major capsid protein HPV 16L1 non-assembly variant in E. coliSemantic proximity Read ↗

N-terminal VP1 Truncations Favor T = 1 Norovirus-Like ParticlesSemantic proximity Read ↗

Production and Characterization of Self-Assembled Virus-like Particles Comprising Capsid Proteins from Genotypes 3 and 4 Hepatitis E Virus (HEV) and Rabbit HEV Expressed in Escherichia coli.Semantic proximity Read ↗

N-terminal VP1 truncations favor <i>T</i> =1 norovirus-like particlesSemantic proximity Read ↗

Oligomerization of PcrV and LcrV, protective antigens of Pseudomonas aeruginosa and Yersinia pestis.Semantic proximity Read ↗

Recombinant expression systems for production of stabilised virus-like particles as next-generation polio vaccinesSemantic proximity Read ↗

Development of Virus-Like Particles (VLPs) for Hepatitis C Virus genotype 4: a novel approach for vaccine development in Egypt.Semantic proximity Read ↗

Rational Engineering of Recombinant Picornavirus Capsids to Produce Safe, Protective Vaccine AntigenSemantic proximity Read ↗

Production of norovirus-, rotavirus-, and enterovirus-like particles in insect cells is simplified by plasmid-based expressionSemantic proximity Read ↗

Risk-free polio vaccine: Recombinant expression systems for production of stabilised virus-like particlesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.